You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
by Deep Bio
AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target
Jennifer Van Eyk
Remote self-sampling may improve diagnosis and prognosis while reducing costs, but numerous factors must be considered for appropriate implementation
In-depth analysis of next-generation sequencing can help personalize cancer treatment and drive the adoption of precision medicine
In today’s increasingly connected society, how can digital pathology facilitate long-distance diagnosis and ease resource pressures across the globe?
An analysis of 1,000 Swedish genomes reveals greater heterogeneity and shows why the human reference genome needs updating
Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers
A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map
Kidney discard rates are higher than ever – but the procurement biopsies that often rule out their use are unreliable and need to be standardized
Higher tumor mutational burden is linked to improved survival across multiple cancer types.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.